Recent Updates
Recently added Catalysts
CRVO

CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference

Key Takeaway: CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference
Price reaction · baseline $13.48 (2024-10-29 close) · hit after-hours · 1 other CRVO headline(s) in the window, move may be shared
day 0 close · peak
+4.5%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
6.8%
average across 6 past catalysts
Cash runway
~10 mo
Medium dilution risk
Lead asset
Neflamapimod
Phase 2 · Moderate to Severe Acute Ischaemic Stroke

Full Press Release Details

CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference.
Last updated: Oct 30, 2024